Answers are grounded in this paper and cite their sources.
Cichorium intybus L. (chicory), Asteraceae, is extensively recognized for its historical and modern uses in healthcare, agriculture, and dietary practices. This study highlights the taxonomy, bioactive compounds, and therapeutic properties of chicory. The species is rich in bioactive substances, such as inulin, phenolic acids (e.g., chlorogenic and caffeic acids), sesquiterpene lactones, and flavonoids (e.g., quercetin and luteolin). These phytochemicals are key to free radical scavenging, inflammation-modulating compounds, hepatoprotective action, microbial growth inhibition, anthelmintic action, and blood sugar regulation. Inulin serves as a prebiotic fiber, promoting gut health and metabolic regulation, while phenolic acids exhibit potent antioxidant and anticancer activities. Sesquiterpene lactones contribute to anti-inflammatory and antimicrobial effects, whereas flavonoids enhance the plant's therapeutic potential by modulating key biological pathways. Chicory's pharmacological applications extend to liver protection, glucose metabolism regulation, and immune modulation, underscoring its potential in managing chronic diseases. Despite its extensive therapeutic profile, further clinical studies are necessary to confirm its efficacy, establish optimal dosages, and explore its long-term safety. This work supports the integration of chicory into functional foods and pharmaceutical formulations, leveraging its diverse health benefits to address global health challenges.
No takes yet. Share an insight, caveat, or question.
Balaž et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: